lifemd glp 1 Integrates with Withings: GLP-1 Weight Loss with In-Home Monitoring LifeMD Partners with Withings to

17 Moreover, other trials as the SUSTAIN-6 trial showed that semaglutide, another GLP-1RA also reduced the risk of MACE by 26% and non-fatal stroke by 39% in patients with T2DM

By 12 months, they were: 40 percent more likely to develop nonscarring hair loss 64 percent more likely to develop pattern thinning 76 percent more likely to experience stress-related shedding, a temporary increase in hair shedding that often shows up a few months after a physical stressor such as illness, surgery, childbirth, or rapid weight loss The study did not find an increased risk of alopecia areata, an autoimmune form of hair loss

Pharmaceutical GLP-1 receptor agonists are licensed for type 2 diabetes and specific obesity indications according to NICE guidance, requiring GP consultation and monitoring

& Sacks, S

Share this post Women's Health More articles

A useful way to set expectations is to compare typical natural approaches against prescription GLP1 receptor agonists